Zobrazeno 1 - 10
of 798
pro vyhledávání: '"D A, Rinaldi"'
Publikováno v:
Dynamic Response and Failure of Composite Materials ISBN: 9783031285462
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d01c2a95f5490b3694216c7cdeef738e
https://doi.org/10.1007/978-3-031-28547-9_27
https://doi.org/10.1007/978-3-031-28547-9_27
Publikováno v:
Journal of Anhui Agricultural Sciences. 11/8/2024, Vol. 52 Issue 21, p78-81. 4p.
Publikováno v:
Anti-Cancer Drugs. 10:393-396
This study evaluated the toxicity and efficacy of topical topitriol (calcitriol, 1,25-dihydroxyvitamin D3) to prevent chemotherapy-induced alopecia (CIA). Patients with breast cancer scheduled to receive FAC chemotherapy (5-fluorouracil, adriamycin a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0641287669f4b8b95902724a0a4d8726
https://doi.org/10.1097/00001813-199904000-00007
https://doi.org/10.1097/00001813-199904000-00007
Autor:
Patrick W. Cobb, L Smith, J. G. Kuhn, Ahmad Awada, D. D. Von Hoff, J R Eckardt, D A Rinaldi, Howard A. Burris, S. Fields
Publikováno v:
Anti-Cancer Drugs. 5:394-402
Topotecan (SKF 104864-A, NSC 609699) is a water-soluble, semi-synthetic analog of camptothecin which is an inhibitor of topoisomerase I. Since topoisomerase I is cell specific for S phase, we undertook a phase I study to determine the maximum tolerat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66a1876d9677409b1423e04d91ef44a5
https://doi.org/10.1097/00001813-199408000-00002
https://doi.org/10.1097/00001813-199408000-00002
Autor:
Brunet, Gerónimo1 (AUTHOR) gbrunet@ei.udelar.edu.uy, Girona, Alejandra2 (AUTHOR), Fajardo, Gabriela2 (AUTHOR), Ares, Gastón3 (AUTHOR)
Publikováno v:
SAGE Open. Oct-Dec2024, Vol. 14 Issue 4, p1-14. 14p.
Autor:
D R, RINALDI
Publikováno v:
Publicaciones. Buenos Aires (Argentina). Centro de Investigaciones Tisiologicas. 10
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7c814643bc13b378005e5423157e87d5
https://pubmed.ncbi.nlm.nih.gov/20240290
https://pubmed.ncbi.nlm.nih.gov/20240290
Autor:
D A, Rinaldi
Publikováno v:
Seminars in oncology. 26(2 Suppl 6)
Multitargeted antifolate (MTA, LY231514) is a novel antifolate antimetabolite, with antitumor activity via inhibition of thymidylate synthase, glycinamide formyl transferase, and dihydrofolate reductase. Three dosing schedules have been investigated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::810eafe6015e7b80cfc62653cb3e2a8e
https://pubmed.ncbi.nlm.nih.gov/10598560
https://pubmed.ncbi.nlm.nih.gov/10598560
Autor:
G I, Rodriguez, J G, Kuhn, G R, Weiss, S G, Hilsenbeck, J R, Eckardt, A, Thurman, D A, Rinaldi, S, Hodges, D D, Von Hoff, E K, Rowinsky
Publikováno v:
Blood. 91(5)
Despite the widespread usage of hydroxyurea in the treatment of both malignant and nonmalignant diseases and a recent expansion in the recognition of its potential therapeutic applications, there have been few detailed studies of hydroxyurea's pharma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::484f6db19a60b2f10310ceb869d22bc7
https://pubmed.ncbi.nlm.nih.gov/9473217
https://pubmed.ncbi.nlm.nih.gov/9473217
Autor:
Fioretti, Vincenzo1,2 (AUTHOR), Sperandeo, Luca2 (AUTHOR), Gerardi, Donato1 (AUTHOR), Di Fazio, Aldo3 (AUTHOR) aldo.difazio@ospedalesancarlo.it, Stabile, Eugenio1 (AUTHOR) eugeniostabile@gmail.com
Publikováno v:
Journal of Clinical Medicine. Jul2024, Vol. 13 Issue 14, p4229. 19p.
Publikováno v:
Boletin de la Oficina Sanitaria Panamericana. Pan American Sanitary Bureau. 121(3)
The sera of 176 patients with epidemiologic antecedents or radiologic and clinical signs of hydatidosis were tested by counter-immunoelectrophoresis (CIE) and enzyme-linked immunoassay (ELISA). A semipurified antigen from cysts of human origin were u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::16ef4aae1ccb0ade1fcb850fe66ee576
https://pubmed.ncbi.nlm.nih.gov/8962664
https://pubmed.ncbi.nlm.nih.gov/8962664